A study published in the November/December issue of the Journal of Opioid Management revealed that a proprietary algorithm offered by Ameritox®, applied to urine drug levels of OxyContin® C-II (oxycodone HCl controlled-release) Tablets, demonstrated excellent ability to differentiate among three different doses of OxyContin® (oxycodone hydrochloride) compared to a traditional urine drug level test. The proprietary algorithm is applied within the company’s Rx Guardian(SM) pain medication monitoring process, designed to provide physicians with additional information about patients’ pain medication use.
Interested in Monitoring? Call 877-596-2224
Current Customers Call 877-296-6465
Patients & Other Questions Call 877-643-6179